193 related articles for article (PubMed ID: 18441512)
1. Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene.
Fukuhara T; Saijo Y; Sakakibara T; Inoue A; Morikawa N; Kanamori M; Nakashima I; Nukiwa T
Tohoku J Exp Med; 2008 Apr; 214(4):359-63. PubMed ID: 18441512
[TBL] [Abstract][Full Text] [Related]
2. Significance of an epidermal growth factor receptor mutation in cerebrospinal fluid for carcinomatous meningitis.
Kanaji N; Bandoh S; Nagamura N; Kushida Y; Haba R; Ishida T
Intern Med; 2007; 46(19):1651-5. PubMed ID: 17917328
[TBL] [Abstract][Full Text] [Related]
3. Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib.
Sakai M; Ishikawa S; Ito H; Ozawa Y; Yamamoto T; Onizuka M; Sakakibara Y
Int J Clin Oncol; 2006 Jun; 11(3):243-5. PubMed ID: 16850132
[TBL] [Abstract][Full Text] [Related]
4. [A case of meningeal carcinomatosis of lung adenocarcinoma well controlled by re-treatment with gefitinib].
Kumamoto T; Suetsugu T; Iwakawa J; Tanoue A; Kawamata Y
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2615-7. PubMed ID: 20009465
[TBL] [Abstract][Full Text] [Related]
5. High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer.
Clarke JL; Pao W; Wu N; Miller VA; Lassman AB
J Neurooncol; 2010 Sep; 99(2):283-6. PubMed ID: 20146086
[TBL] [Abstract][Full Text] [Related]
6. Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutations.
Shen YC; Tseng GC; Tu CY; Chen WC; Liao WC; Chen WC; Li CH; Chen HJ; Hsia TC
Lung Cancer; 2017 Aug; 110():56-62. PubMed ID: 28676220
[TBL] [Abstract][Full Text] [Related]
7. EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.
Yu G; Xie X; Sun D; Geng J; Fu F; Zhang L; Wang H
Int J Clin Exp Pathol; 2015; 8(7):8603-6. PubMed ID: 26339441
[TBL] [Abstract][Full Text] [Related]
8. Gefitinib and a ventriculo-peritoneal shunt to manage carcinomatous meningitis from non-small-cell lung cancer: report of two cases.
So T; Inoue M; Chikaishi Y; Nose N; Sugio K; Yasumoto K
Surg Today; 2009; 39(7):598-602. PubMed ID: 19562448
[TBL] [Abstract][Full Text] [Related]
9. [Gefitinib treatment for carcinomatous meningitis in non-small cell lung cancer].
Chouahnia K; Brechot JM; Des-Guetz G; Saintigny P; Morere JF; Breau JL
Rev Mal Respir; 2006 Apr; 23(2 Pt 1):149-51. PubMed ID: 16788439
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib.
Katayama T; Shimizu J; Suda K; Onozato R; Fukui T; Ito S; Hatooka S; Sueda T; Hida T; Yatabe Y; Mitsudomi T
J Thorac Oncol; 2009 Nov; 4(11):1415-9. PubMed ID: 19692934
[TBL] [Abstract][Full Text] [Related]
11. Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma.
Ferreira Filho AF; Cardoso F; Di Leo A; Awada A; da Silva VD; Tovar RB; Schwartsmann G
Ann Oncol; 2001 Dec; 12(12):1757-9. PubMed ID: 11843255
[TBL] [Abstract][Full Text] [Related]
12. The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy.
Yang CJ; Hung JY; Tsai MJ; Wu KL; Liu TC; Chou SH; Lee JY; Hsu JS; Huang MS; Chong IW
BMC Pharmacol Toxicol; 2017 May; 18(1):21. PubMed ID: 28486985
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the lung with rare insertion mutation in EGFR exon 19 that had partial response to gefitinib: a case report.
Kozlov V; Karpov I; Kovalenko S; Shamanin V
Exp Oncol; 2017 Jul; 39(2):155-156. PubMed ID: 29483495
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of low-dose erlotinib against gefitinib-induced hepatotoxicity in a patient with lung adenocarcinoma harboring EGFR mutations].
Kitade H; Yamada T; Igarashi S; Hokkoku K; Mori M; Shintaku K; Sagawa M; Nakai M; Yano S
Gan To Kagaku Ryoho; 2013 Jan; 40(1):79-81. PubMed ID: 23306923
[TBL] [Abstract][Full Text] [Related]
15. Long-term response to gefitinib and crizotinib in lung adenocarcinoma harboring both epidermal growth factor receptor mutation and EML4-ALK fusion gene.
Chiari R; Duranti S; Ludovini V; Bellezza G; Pireddu A; Minotti V; Bennati C; Crinò L
J Clin Oncol; 2014 Mar; 32(9):e30-2. PubMed ID: 24419120
[No Abstract] [Full Text] [Related]
16. Leukocyte Telomere Length and Clinical Outcomes of Advanced Lung Adenocarcinoma Patients with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment.
Li J; Zhang L; Zhu H; Pan W; Zhang N; Li Y; Yang M
DNA Cell Biol; 2018 Nov; 37(11):903-908. PubMed ID: 30277797
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).
Miyauchi E; Inoue A; Kobayashi K; Maemondo M; Sugawara S; Oizumi S; Isobe H; Gemma A; Saijo Y; Yoshizawa H; Hagiwara K; Nukiwa T;
Jpn J Clin Oncol; 2015 Jul; 45(7):670-6. PubMed ID: 25877748
[TBL] [Abstract][Full Text] [Related]
18. Successful re-treatment with gefitinib for carcinomatous meningitis as disease recurrence of non-small-cell lung cancer.
Hashimoto N; Imaizumi K; Honda T; Kawabe T; Nagasaka T; Shimokata K; Hasegawa Y
Lung Cancer; 2006 Sep; 53(3):387-90. PubMed ID: 16824645
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics and long-term therapeutic effects of gefitinib in patients with lung adenocarcinoma harboring the epidermal growth factor receptor(EGFR)mutation.
Hirano S; Sano K; Takeda Y; Ishii S; Naka G; Iikura M; Izumi S; Hojo M; Sugiyama H; Kobayashi N; Kudo K
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1501-6. PubMed ID: 23064060
[TBL] [Abstract][Full Text] [Related]
20. Focal leptomeningeal metastasis following curative surgery for lung cancer: case report.
Takahashi M; Soejima Y; Yamamoto J; Saito T; Nishizawa S
Neurol Med Chir (Tokyo); 2011; 51(3):247-50. PubMed ID: 21441747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
